期刊論文1. | O'Neill, O.(2004)。Accountability, trust and informed consent in medical practice and research。Clinical Medicine,4(3),269-276。 |
2. | Lazarus, Jeffrey V.、Ratzan, Scott C.、Palayew, Adam、Gostin, Lawrence O.、Larson, Heidi J.、Rabin, K.、Kimball, Spencer、El-Mohandes, A.(2021)。A global survey of potential acceptance of a COVID-19 vaccine。Nature Medicine,27(2),225-228。 |
3. | 王竣鋒(2021)。美國FDA於2021年2月更新「預防COVID-19疫苗之緊急使用授權」指引。當代醫藥法規月刊,127,23-24。 延伸查詢 |
4. | 邱鈺婷(2020)。歐盟EMA於2020年11月發表「COVID-19疫苗相關之安全監視計畫及風險管理計畫」指引。當代醫藥法規月刊,122,34-35。 延伸查詢 |
5. | 陳毓茹(2021)。歐盟EMA於2020年11月發表「對於COVID-19疫苗核准的考量」觀點討論。當代醫藥法規月刊,124,41-42。 延伸查詢 |
6. | 莫奈河(20210902)。誰讓戰略產業--高端疫苗成為「一代拳王」?。新新聞,2021(9月號)。 延伸查詢 |
7. | 黃天如(20210804)。審查委員條件全淪建議!高端EUA標準全球首創.賴明詔提混打試驗救民心。新新聞,2021(8月號)。 延伸查詢 |
8. | Forman, Rebecca、Shah, Soleil、Jeurissen, Patrick、Jit, Mark、Mossialos, Elias(2021)。COVID-19 vaccine challenges: What have we learned so far and what remains to be done?。Health Policy,125(5),553-567。 |
9. | Harris, Phil、Moss, Danny(2021)。Public affairs and communicating coronavirus vaccine risk: The role of government in maintaining public trust。Journal of Public Affairs,21(2)。 |
10. | O'Neill, Onora(2018)。Linking Trust to Trustworthiness。International Journal of Philosophical Studies,26(2),293-300。 |
11. | Blanchard, Jaymie-Lynn、Johnson, Caitlin、McIntyre, Margaret、Crowcroft, Natasha S.、McLellan, Andrea(2020)。A pre and post intervention study measuring the effect of interactive education on adolescent perceptions of vaccines, vaccine safety and disease risk。Journal of Public Health,42(3),e272-e277。 |
12. | Petersen, Michael Bang、Bor, Alexander、Jørgensen, Frederik、Lindholt, Marie Fly(2021)。Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust。Proceedings of the National Academy of Sciences,118(29)。 |
13. | Bolsen, Toby、Druckman, James N.(2015)。Counteracting the Politicization of Science。Journal of Communication,65(5),745-769。 |
14. | Kreps, S. E.、Kriner, D. L.(2020)。Model uncertainty, political contestation, and public trust in science: Evidence from the COVID-19 pandemic。Science Advances,6(43)。 |
15. | (2020)。COVID vaccines: the world's medical regulators need access to open data。Nature,588。 |
16. | Dawson, Angus(2020)。Pandemic vaccine trials: expedite, but don't rush。Research Ethics,16(3/4),1-12。 |
其他1. | 謝柏宏(2020)。本土新冠疫苗臨床標準變嚴,https://udn.com/news/story/7241/4966106。 延伸查詢 |
2. | 林育瑄(20210611)。以免疫橋接方式審EUA臺灣首創?陳時中:WHO有討論,https://www.cna.com.tw/news/aipl/202106110115.aspx。 延伸查詢 |
3. | 陳潔(20210309)。疫苗進行式:COVID-19全球疫苗接種即時追蹤,https://www.twreporter.org/a/covid-19-vaccinations-across-the-world。 延伸查詢 |
4. | 陳潔,嚴文廷,楊惠君(2021)。首支取得EUA的國產高端疫苗,防疫角色如何定位?保護力監測與國際接軌考驗在哪?,https://www.twreporter.org/a/covid-19-medigen-vaccines-eua。 延伸查詢 |
5. | 楊惠君,陳潔(20210608)。COVID-19國產疫苗信任危機走火關鍵:比臨床試驗更需要「解盲」的決策過程,https://www.twreporter.org/a/covid-19-vaccine-trust-crisis。 延伸查詢 |
6. | FDA(2021)。The Path for a COVID-19 Vaccine from Research to Emergency Use Authorization,https://www.fda.gov/media/143890/download。 |
7. | O'Neill, Onora(2017)。Trust, Trustworthiness And Transparency,https://www.thebritishacademy.ac.uk/documents/2563/Future-of-the-corporation-Trust-trustworthiness-transparency.pdf。 |